Ishares Core Hang Seng Index ETF(03115.HK) Rose 0.37% to 96.760
Newtimespace News, as of 11:24 on May 14, Ishares Core Hang Seng Index ETF(03115.HK) was quoted at HKD 96.760, up 0.37%. The ETF opened at HKD 97.000, with a high of HKD 98.000 and a low of HKD 97.000. The latest NAV per unit is HKD 96.401, with a premium rate of -0.04%. The asset size is approximately HKD 2.396 billion.
Ishares Core Hang Seng Index ETF(03115.HK) tracks the Hang Seng Index, which is compiled and published by Hang Seng Indexes Company Limited. The index is the most representative benchmark for the Hong Kong stock market. Its constituents span four major industry categories: Finance, Properties & Construction, Utilities, and Commerce & Industry, aiming to reflect the overall performance of large companies listed in Hong Kong. The index includes leading market blue-chip companies such as Tencent Holdings, Alibaba, HSBC Holdings, and AIA Group, making it a key benchmark indicator for gauging the performance of the Hong Kong stock market.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- TAN CHONG INT'L (00693.HK): Expected Unrealised Investment Loss of HK$512 Million for First Half Due to Share Price Movements of Listed Investments
- SBP GROUP (01177.HK): NDA Accepted for Category 1 Innovative Drug IDH1 Inhibitor TQB3454 for Advanced Biliary Tract Cancer
- Pizu Group(09893.HK): Change of Independent Non-executive Director, Appointment of Wei Lai
- DUFU LIQUOR GP (00986.HK): Li Jingfu Appointed CEO of Subsidiary to Lead Research on AI Digital Human and Internet Marketing Business
- SSY GROUP (02005.HK): Propylthiouracil Tablets and Calcium Gluconate and Sodium Chloride Injection Obtain Drug Registration Approvals, Deemed to Have Passed Consistency Evaluation